GAL-160
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
GAL‐160 is a novel chemoreceptor modulator entering early clinical development as a therapeutic for sleep‐disordered breathing…
OIRD may result, at least in part, from decreased CO2 chemosensitivity. Previously, we reported that GAL‐021 administered IV…